These findings are consistent with studies by Kang et al. [25], Chen et al. [26], and Liu et al. [27], which demonstrated lower adiponectin levels in T2DM patients and their correlations with various metabolic markers. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.